Ionis Pharmaceuticals (IONS) Tops Q4 EPS by 35c, Revenues Beat; Offers FY20 Revenue Outlook Below Consensus

Go back to Ionis Pharmaceuticals (IONS) Tops Q4 EPS by 35c, Revenues Beat; Offers FY20 Revenue Outlook Below Consensus
(NASDAQ: IONS) Delayed: 44.44 --0 (-0%)
Previous Close $44.44    52 Week High $62.68 
Open $44.44    52 Week Low $19.59 
Day High $44.44    P/E N/A 
Day Low $44.44    EPS $0.00 
Volume 918